ANA ISABEL
SÁNCHEZ FRUCTUOSO
Profesora titular de universidad
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (21)
2024
-
Tubulo-interstitial inflammation increases the risk of graft loss after the recurrence of IgA nephropathy
Clinical Kidney Journal, Vol. 17, Núm. 1
2023
-
Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients
Nefrologia, Vol. 43, Núm. 5, pp. 531-545
2020
-
Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study
Clinical Transplantation, Vol. 34, Núm. 1
-
Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients
Nefrologia, Vol. 40, Núm. 3, pp. 265-271
-
Uncontrolled donation after circulatory death: A unique opportunity
Transplantation, Vol. 104, Núm. 8, pp. 1542-1552
2019
-
Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience
Kidney International, Vol. 95, Núm. 2, pp. 420-428
2016
-
Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation
Transplant International, Vol. 29, Núm. 12, pp. 1317-1328
-
Open-Label, Randomized Study of Transition from Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
Transplantation Direct, Vol. 2, Núm. 4
-
Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging
Transplant International, Vol. 29, Núm. 9, pp. 1008-1016
2013
-
A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation
American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500
2012
-
Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: The AnemiaTrans study
Advances in Therapy, Vol. 29, Núm. 11, pp. 979-991
-
Avances en la inmunosupresión para el trasplante renal. Nuevas estrategias para preservar la función renal y reducir el riesgo cardiovascular
Nefrologia, Vol. 32, Núm. 3, pp. 374-384
2011
-
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients
American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971
-
Erratum: Estimation of renal allograft half-life: Fact or fiction? (Nephrology Dialysis Transplantation (2011) 26 (30133018) DOI 10.1093/ndt/gfq788)
Nephrology Dialysis Transplantation
2010
-
Anemia control in kidney transplant patients treated with methoxy polyethylene glycol-epoetin beta (Mircera): The anemiatrans group
Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2931-2934
2009
-
A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year
Transplantation, Vol. 88, Núm. 6, pp. 803-809
2008
-
Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus
Transplantation, Vol. 86, Núm. 4, pp. 620-622
2007
-
Early Sirolimus Use With Cyclosporine Elimination Does Not Induce Progressive Proteinuria
Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2151-2152
2006
-
Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction
Nephrology Dialysis Transplantation, Vol. 21, Núm. 11, pp. 3252-3257
2005
-
Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma
Transplantation Proceedings